Want to join the conversation?
During 4Q16, $BR's ICS segment recurring and total revenues grew 7% and 5%, respectively, as the position growth dynamics resulted in relatively light internal growth. Pretax earnings grew 7% in ICS. GTO segment posted 7% revenue growth & 24% pretax earnings growth continuing to work through a conversion backlog related to 2 strong sales years.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?